The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means RFK Jr. & claimed regenerative peptides like BPC 157 The Niche BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options The Blacklisting of Peptides